Results 11 to 20 of about 104,102 (262)

Clinical, laboratory features and prognosis of children receiving IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective single-center experience (PIGMENT study)

open access: yesHuman Vaccines & Immunotherapeutics, 2020
Introduction Although there are studies about sepsis treatment in different age groups, data on immunoglobulin-M (IgM)-enriched intravenous immunoglobulin use in pediatric intensive care units (PICUs) are limited.
Emin Abdullayev   +5 more
doaj   +1 more source

Intravenous immunoglobulins: a treatment for Alzheimer's disease? [PDF]

open access: yesJournal of Neurology, Neurosurgery & Psychiatry, 2004
A novel therapeutic option for Alzheimer’s disease Aβ-peptide is generally considered to play a central role in the pathogenesis of Alzheimer’s disease (AD). The peptide is cleaved from amyloid precursor protein (APP) by secretases and is a key component of the amyloid plaques.
Hack, C. E., Scheltens, P.
openaire   +2 more sources

INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRIC RHEUMATOLOGY PRACTICE

open access: yesВопросы современной педиатрии, 2015
Modern successful treatment of rheumatic diseases is impossible without the use of intravenous immunoglobulin. The use of intravenous immunoglobulin is based on strict indications developed as a result of long-term multicenter controlled studies.
E. I. Alexeeva   +2 more
doaj   +1 more source

Use of intravenous immunoglobulin for the treatment of autoimmune encephalitis: audit of the NHS experience

open access: yesJRSM Open, 2018
Objectives The treatments of limbic and other autoimmune encephalitis include immunosuppression, symptomatic treatment, and in the case of paraneoplastic syndromes, appropriate therapy for underlying neoplasms.
JA Kinsella   +7 more
doaj   +1 more source

Subcutaneous immunoglobulin in lymphoproliferative disorders and rituximab-related secondary hypogammaglobulinemia: a single-center experience in 61 patients

open access: yesHaematologica, 2014
Intravenous immunoglobulin replacement therapy represents the standard treatment for hypogammaglobulinemia secondary to B-cell lymphoproliferative disorders. Subcutaneous immunoglobulin infusion is an effective, safe and well-tolerated treatment approach
Nicolò Compagno   +3 more
doaj   +1 more source

Evaluation of high-dose aspirin elimination in the treatment of Kawasaki disease in the incidence of coronary artery aneurysm

open access: yesAnnals of Pediatric Cardiology, 2021
Background: Standard first-step therapy for Kawasaki disease consists of Intravenous immunoglobulin and high dose Aspirin (80-100 mg/kg/day). The standard dose of Intravenous immunoglobulin (2gr/kg) is strongly effective in reducing the risk of coronary ...
Farima Sanati   +3 more
doaj   +1 more source

A serious thrombotic event in a patient with immune thrombocytopenia requiring intravenous immunoglobulin: a case report

open access: yesJournal of Medical Case Reports, 2019
Background Immune thrombocytopenia is an acquired autoimmune disease. Recently, there has been evidence of thrombotic risk in patients with immune thrombocytopenia, but the mechanism is still inconclusive.
Tarinee Rungjirajittranon   +1 more
doaj   +1 more source

Severe aquaporin 4-IgG-positive neuromyelitis optica with disseminated herpes zoster in a pregnant woman successfully treated with intravenous immunoglobulin

open access: yesMultiple Sclerosis Journal - Experimental, Translational and Clinical, 2018
A 26-year-old, 17-week pregnant woman developed aquaporin-4-IgG-positive severe longitudinally extensive transverse myelitis during the course of disseminated herpes zoster and became quadriparetic.
Yuki Matsumoto   +7 more
doaj   +1 more source

Clinical Outcome of Intravenous Immunoglobulin in the treatment of Guillain Barre Syndrome in a Nepalese Tertiary Centre

open access: yesNepalese Medical Journal, 2019
Introduction: Intravenous Immunoglobulin is an approved therapy for Guillain Barre Syndrome. Our objective is to understand the management and outcome in Guillain Barre Syndrome patients treated with Immunoglobulin. Materials and Methods: All consecutive
Rajeev Ojha, Ragesh Karn
doaj   +1 more source

Intravenous Immunoglobulin Therapy-Induced Erythema Multiforme in a Patient with Chronic Lymphocytic Leukemia

open access: yesCase Reports in Dermatology, 2023
This case report discusses immunoglobulin-induced erythema multiforme (EM), a rare and understudied condition that requires further investigation. The report presents the case of a 69-year-old woman with a history of chronic lymphocytic leukemia who ...
Angelina Konovalova   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy